BIOFRONTERA AG NA O.N./ DE0006046113 /
| 2024-04-18 8:07:06 AM | Chg. +0.0140 | Volume | Bid1:30:00 PM | Ask1:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.3160EUR | +4.64% | 0 Turnover: 0.0000 |
0.3220Bid Size: 1,000 | 0.3540Ask Size: 1,000 | 19.85 mill.EUR | 0.00% | 0.51 |
Assets
| 2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .3000 | .3000 | .2000 | .3000 | .5000 | ||||||
| Intangible Assets | 1.4000 | 1.3000 | 4.3000 | 3.8000 | 3.2000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 1.8000 | 1.5000 | 4.6000 | 4.1000 | 3.7000 | ||||||
| Inventories | .1000 | .2000 | .5000 | .9000 | .8000 | ||||||
| Accounts Receivable | 0.0000 | 0.0000 | 0.0000 | .3000 | .6000 | ||||||
| Cash and Cash Equivalents | 1.4000 | .7000 | .6000 | 3.4000 | 2.9000 | ||||||
| Current Assets | 1.6000 | 1.1000 | 1.1000 | 5 | 6 | ||||||
| Total Assets | 3.4000 | 2.6000 | 5.7000 | 9 | 9.6000 | ||||||
Liabilities
| 2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .6000 | .5000 | .7000 | .7000 | .7000 | ||||||
| Long-term debt | 11.3000 | 12.7000 | 10.6000 | 11.2000 | 12 | ||||||
| Liabilities to Banks | 12.6000 | 12.7000 | 16.9000 | 11.6000 | 12.4000 | ||||||
| Provisions | .5000 | 2.2000 | .5000 | .7000 | .9100 | ||||||
| Liabilities | 13.7000 | 15.5000 | 18.2000 | 14.2000 | 14.2000 | ||||||
| Share Capital | 7.6000 | 10 | 11.2000 | 16.1000 | 17.8000 | ||||||
| Total Equity | -10.4000 | -12.9000 | -12.5000 | -4.1000 | -4.5000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 3.4000 | 2.6000 | 5.7000 | 9 | 9.6000 | ||||||
Income Statement
| 2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | .3000 | .4000 | .5000 | 3.4000 | 3.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -5.4000 | -6.1000 | -4.4000 | -3.6000 | -7.1000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -3.3000 | -7.7000 | -4.6000 | -4.1000 | -8.1000 | ||||||
| Income Taxes | .1000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -3.4000 | -7.7000 | -4.6000 | -4.1000 | -8.1000 | ||||||
Per Share
Cash Flow
| 2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -3.7000 | -5.6000 | -4.7000 | -5.2000 | -7.7000 | ||||||
| Cash Flow from Investing Activities | .4000 | 0.0000 | -.3000 | -.1000 | -.3000 | ||||||
| Cash Flow from Financing | 4.5000 | 4.9000 | 4.8000 | 8.1000 | 7.6000 | ||||||
| Decrease / Increase in Cash | 1.3000 | -.7000 | -.1000 | 2.8000 | -.4000 | ||||||
| Employees | 23 | 20 | 27 | 34 | 38 | ||||||
